202 related articles for article (PubMed ID: 19522698)
1. Emerging therapeutic agents for cervical cancer.
Cornelio DB; Roesler R; Schwartsmann G
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):196-206. PubMed ID: 19522698
[TBL] [Abstract][Full Text] [Related]
2. Using cytokines to treat cervical intraepithelial and invasive neoplasia.
Tirone NR; Michelin MA; Murta EF
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):165-9. PubMed ID: 19961435
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and targeted therapy for cervical cancer: an update.
Menderes G; Black J; Schwab CL; Santin AD
Expert Rev Anticancer Ther; 2016; 16(1):83-98. PubMed ID: 26568261
[TBL] [Abstract][Full Text] [Related]
5. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
6. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for cervical cancer: Can it do another lung cancer?
Ramanathan P; Dhandapani H; Jayakumar H; Seetharaman A; Thangarajan R
Curr Probl Cancer; 2018; 42(2):148-160. PubMed ID: 29500076
[TBL] [Abstract][Full Text] [Related]
8. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy: an evolving paradigm in the treatment of advanced cervical cancer.
Eskander RN; Tewari KS
Clin Ther; 2015 Jan; 37(1):20-38. PubMed ID: 25592089
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.
Roszik J; Ring KL; Wani KM; Lazar AJ; Yemelyanova AV; Soliman PT; Frumovitz M; Jazaeri AA
Front Immunol; 2018; 9():2102. PubMed ID: 30283446
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy in cervical cancer: 30 years in review.
Liontos M; Kyriazoglou A; Dimitriadis I; Dimopoulos MA; Bamias A
Crit Rev Oncol Hematol; 2019 May; 137():9-17. PubMed ID: 31014518
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic cervical cancer: future directions involving targeted agents.
Diaz-Padilla I; Monk BJ; Mackay HJ; Oaknin A
Crit Rev Oncol Hematol; 2013 Mar; 85(3):303-14. PubMed ID: 22883215
[TBL] [Abstract][Full Text] [Related]
13. Investigational drugs for the treatment of cervical cancer.
Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.
Feng CH; Mell LK; Sharabi AB; McHale M; Mayadev JS
Semin Radiat Oncol; 2020 Oct; 30(4):273-280. PubMed ID: 32828383
[TBL] [Abstract][Full Text] [Related]
15. Update on novel therapeutic agents for cervical cancer.
del Campo JM; Prat A; Gil-Moreno A; Pérez J; Parera M
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S72-6. PubMed ID: 18544460
[TBL] [Abstract][Full Text] [Related]
16. Management of cervical cancer.
Kesic V
Eur J Surg Oncol; 2006 Oct; 32(8):832-7. PubMed ID: 16698223
[TBL] [Abstract][Full Text] [Related]
17. New strategies in advanced cervical cancer: from angiogenesis blockade to immunotherapy.
Tewari KS; Monk BJ
Clin Cancer Res; 2014 Nov; 20(21):5349-58. PubMed ID: 25104084
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
Pathak K; Akhtar N
Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for recurrent and metastatic cervical cancer.
Tao X; Hu W; Ramirez PT; Kavanagh JJ
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions.
Kagabu M; Nagasawa T; Sato C; Fukagawa Y; Kawamura H; Tomabechi H; Takemoto S; Shoji T; Baba T
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
